Journal article

Natural killer T cell defects in multiple myeloma and the impact of lenalidomide therapy

AC Chan, P Neeson, E Leeansyah, K Tainton, H Quach, HM Prince, SJ Harrison, DI Godfrey, D Ritchie, SP Berzins

CLINICAL AND EXPERIMENTAL IMMUNOLOGY | WILEY | Published : 2014

Grants

Awarded by National Health and Medical Research Council (NHMRC)


Awarded by NHMRC Program


Funding Acknowledgements

The authors gratefully acknowledge the participation of patients and blood donors in the study, and the contributions of Rhonda Holdsworth (Australian Red Cross Blood Bank) and Kon Kyparissoudis (research assistant). The authors acknowledge the generous funding of this study by the National Health and Medical Research Council (NHMRC), Project grant (no. 454363), the Fiona Elsey Cancer Research Institute (FECRI) and the Victorian Cancer Agency. The authors also acknowledge the following funding support for this research: S. P. B. is a recipient of an NHMRC Career Development Award and current Research Fellowships from University of Ballarat (Robert H. T. Smith Fellowship) and FECRI (Dorevitch Research Fellowship); D. I. G. is supported by an NHMRC Program grant (no. 251608, renewed as no. 454569) and an NHMRC Senior Principal Research Fellowship.